Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy

Over 90% of patients treated for head and neck cancer with curatively aimed chemo or bioradiotherapy will develop painful mucositis and xerostomia. Sublingually delivered fentanyl (SDL) is a rapid acting opioid to treat breakthrough pain. It is unclear how SDL is absorbed by the mucosa of these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuip, Evelien J. M., Oldenmenger, Wendy H., Oomen-de Hoop, Esther, Verduijn, Gerda M., Thijs-Visser, Martine F., de Bruijn, Peter, van Meerten, Esther, Koolen, Stijn L. W., Mathijssen, Ron H. J., van der Rijt, Carin C. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266947/
https://www.ncbi.nlm.nih.gov/pubmed/30445772
http://dx.doi.org/10.3390/cancers10110445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266947/
https://www.ncbi.nlm.nih.gov/pubmed/30445772
http://dx.doi.org/10.3390/cancers10110445

Ejemplares similares